Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: enGene Therapeutics Inc., 2 years.
enGene Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2024 | enGene Therapeutics Inc. | Grant or award | +644,965 | $10.00 | $6,449,650 |
| Feb 20, 2024 | enGene Therapeutics Inc. | Grant or award | +155,035 | $10.00 | $1,550,350 |
| Oct 31, 2023 | enGene Therapeutics Inc. | Grant or award | +1,341,790 | — | — |
| Oct 31, 2023 | enGene Therapeutics Inc. | Grant or award | +44,647 | — | — |
| Oct 31, 2023 | enGene Therapeutics Inc. | Grant or award | +348,686 | — | — |
| Oct 31, 2023 | enGene Therapeutics Inc. | Grant or award | +83,816 | — | — |
| Oct 31, 2023 | enGene Therapeutics Inc. | Grant or award | +1,077,386 | — | — |
| Oct 31, 2023 | enGene Therapeutics Inc. | Grant or award | +152,974 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.